A new way to reverse Alzheimer’s has been discovered by scientists at the Massachusetts Institute of Technology (MIT) — a major breakthrough with ‘dramatic’ results.
The researchers used a peptide, or string of amino acids, to interfere with an enzyme that is typically overactive in the brains of people with the disease.
The chemical compound stops an enzyme, called CDK15, in the brain linked to Alzheimer’s from becoming overactivated and harming neurons — causing cognitive decline.
Researchers hope their findings could serve as the center of future research into a drug that can reverse the disease’s devastating effect.
Li-Huei Tsai, the study’s senior author from MIT, said: ‘We found that the effect of this peptide is just remarkable. We saw wonderful effects in terms of reducing neurodegeneration and neuroinflammatory responses, and even rescuing behavior deficits.’link